Literature DB >> 25721876

APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese.

Daisuke Sakurai1, Yasumasa Iwatani, Hitoshi Ohtani, Taeko K Naruse, Hiroshi Terunuma, Wataru Sugiura, Akinori Kimura.   

Abstract

Human APOBEC3H (A3H) is a member of APOBEC3 cytidine deaminase family that potently restricts HIV-1 replication. Because A3H is genetically divergent with different intracellular stability and anti-HIV-1 activity in vitro, we investigated a possible association of A3H with susceptibility to HIV-1 infection and disease progression in Japanese populations. A total of 191 HIV-1-infected individuals (HIV group), 93 long-term non-progressors to AIDS (LTNP group) and 421 healthy controls were genotyped for two functional APOBEC3H polymorphisms, rs139292 and rs139297. As compared with the controls, minor allele frequency (MAF) for rs139292 was high in the HIV group (MAF in cases vs. controls; 0.322 vs. 0.263, odds ratio (OR) = 1.33, 95% confidence interval (95% CI) = 1.02-1.74, p = 0.035) and low in the LTNP group (0.161 vs. 0.263, OR = 0.54, 95% CI = 0.36-0.82, p = 0.004, pc = 0.007), whereas the MAF for rs139297 was high in the HIV group (0.367 vs. 0.298, OR = 1.36, 95% CI = 1.07-1.76, p = 0.017, pc = 0.035). In addition, haplotype analyses revealed that the frequencies of A3H-hapC and -hapA were high (0.322 vs. 0.262, OR = 1.33, 95% CI = 1.02-1.74, p = 0.003) and low (0.634 vs. 0.697, OR = 0.75, 95 % CI = 0.58-0.97, p = 0.002), respectively, in the HIV group, whereas the frequencies of A3H-hapC and -hapB were low (0.161 vs. 0.262, OR = 0.54, 95% CI = 0.36-0.82, p = 0.00003) and high (0.097 vs. 0.040, OR = 2.55, 95% CI = 1.40-4.62, p = 0.000008), respectively, in the LTNP group, as compared with those in the controls. These observations suggest that the A3H with low anti-HIV-1 activity, A3H-hapC, is associated with the susceptibility to HIV-1 infection, whereas the A3H producing a stable protein, A3H-hapB, may confer a low risk of disease progression to AIDS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25721876     DOI: 10.1007/s00251-015-0829-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  21 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population.

Authors:  Slavé Petrovski; Jacques Fellay; Kevin V Shianna; Nicole Carpenetti; Johnstone Kumwenda; Gift Kamanga; Deborah D Kamwendo; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Myron S Cohen; David B Goldstein
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

3.  Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection.

Authors:  Leslie W Chinn; Minzhong Tang; Bailey D Kessing; James A Lautenberger; Jennifer L Troyer; Michael J Malasky; Carl McIntosh; Gregory D Kirk; Steven M Wolinsky; Susan P Buchbinder; Edward D Gomperts; James J Goedert; Stephen J O'Brien
Journal:  J Infect Dis       Date:  2010-12-15       Impact factor: 5.226

4.  Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.

Authors:  Lindi Tan; Phuong Thi Nguyen Sarkis; Tao Wang; Chunjuan Tian; Xiao-Fang Yu
Journal:  FASEB J       Date:  2008-09-30       Impact factor: 5.191

5.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

6.  A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Authors:  Anjie Zhen; Tao Wang; Ke Zhao; Yong Xiong; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  Human cytidine deaminase APOBEC3H restricts HIV-1 replication.

Authors:  Ying Dang; Lai Mun Siew; Xiaojun Wang; Yanxing Han; Russell Lampen; Yong-Hui Zheng
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

8.  Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.

Authors:  Molly OhAinle; Julie A Kerns; Melody M H Li; Harmit S Malik; Michael Emerman
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

9.  Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS.

Authors:  Sigrid Le Clerc; Cédric Coulonges; Olivier Delaneau; Danielle Van Manen; Joshua T Herbeck; Sophie Limou; Ping An; Jeremy J Martinson; Jean-Louis Spadoni; Amu Therwath; Jan H Veldink; Leonard H van den Berg; Lieng Taing; Taoufik Labib; Safa Mellak; Matthieu Montes; Jean-François Delfraissy; François Schächter; Cheryl Winkler; Philippe Froguel; James I Mullins; Hanneke Schuitemaker; Jean-François Zagury
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

10.  Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.

Authors:  Anjie Zhen; Juan Du; Xiaohong Zhou; Yong Xiong; Xiao-Fang Yu
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more
  12 in total

1.  Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.

Authors:  Yuqing Feng; Robin P Love; Anjuman Ara; Tayyba T Baig; Madison B Adolph; Linda Chelico
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

2.  Recurrent Loss of APOBEC3H Activity during Primate Evolution.

Authors:  Erin I Garcia; Michael Emerman
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

3.  Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification.

Authors:  Jiang Gu; Qihan Chen; Xiao Xiao; Fumiaki Ito; Aaron Wolfe; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2016-08-14       Impact factor: 5.469

Review 4.  The APOBEC Protein Family: United by Structure, Divergent in Function.

Authors:  Jason D Salter; Ryan P Bennett; Harold C Smith
Journal:  Trends Biochem Sci       Date:  2016-06-06       Impact factor: 13.807

5.  APOBEC3H polymorphisms and susceptibility to HIV-1 infection in an Indian population.

Authors:  Taeko K Naruse; Daisuke Sakurai; Hitoshi Ohtani; Gaurav Sharma; Surendra K Sharma; Madhu Vajpayee; Narinder K Mehra; Gurvinder Kaur; Akinori Kimura
Journal:  J Hum Genet       Date:  2015-11-12       Impact factor: 3.172

6.  A Single Nucleotide Polymorphism in Human APOBEC3C Enhances Restriction of Lentiviruses.

Authors:  Cristina J Wittkopp; Madison B Adolph; Lily I Wu; Linda Chelico; Michael Emerman
Journal:  PLoS Pathog       Date:  2016-10-12       Impact factor: 6.823

7.  Stably expressed APOBEC3H forms a barrier for cross-species transmission of simian immunodeficiency virus of chimpanzee to humans.

Authors:  Zeli Zhang; Qinyong Gu; Marc de Manuel Montero; Ignacio G Bravo; Tomas Marques-Bonet; Dieter Häussinger; Carsten Münk
Journal:  PLoS Pathog       Date:  2017-12-21       Impact factor: 6.823

8.  Association of interleukin-27 gene polymorphisms with susceptibility to HIV infection and disease progression.

Authors:  Xiao-Xia Pang; Shun-Da Luo; Ting Zhang; Feng Shi; Chun-Fang Wang; Xing-Hong Chen; Yu-Xia Wei; Li Qin; Jing-Xi Wei; Xiao-Qiong Luo; Jun-Li Wang
Journal:  J Cell Mol Med       Date:  2019-01-10       Impact factor: 5.310

9.  Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients.

Authors:  José M Benito; Julia Hillung; Clara Restrepo; José M Cuevas; Agathe León; Ezequiel Ruiz-Mateos; Rosario Palacios-Muñoz; Miguel Górgolas; Rafael Sanjuán; Norma Rallón
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

Review 10.  Feline APOBEC3s, Barriers to Cross-Species Transmission of FIV?

Authors:  Zeli Zhang; Qinyong Gu; Daniela Marino; Kyeong-Lim Lee; Il-Keun Kong; Dieter Häussinger; Carsten Münk
Journal:  Viruses       Date:  2018-04-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.